ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 032,42
0,49%
Dow Jones
38 686,32
1,51%
DAX
18 617,93
0,73%
Brent Oil
81,125
0,40%
Bitcoin
68 856,93
1,64%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Canadá
  5. TSX
  6. Medicenna Therapeutics Corp (MDNA)

  7. Medicenna Therapeutics Corp (MDNA) Actualités

MDNA Medicenna Therapeutics Corp

2,85
0,53 (22,84%)
31 Mai 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Medicenna Therapeutics Corp MDNA Toronto Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,53 22,84% 2,85 22:00:02
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
2,37 2,29 2,85 2,85 2,32
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
31/5/202415:29GLOBEMedicenna To Present Evidence of Durable Single Agent..
22/5/202413:00GLOBEMedicenna to Present Clinical Update on the MDNA11 ABILITY-1..
13/5/202413:00GLOBEMedicenna Provides Update on its Presentations at the 2024..
30/4/202417:07GLOBEMedicenna Therapeutics Announces Closing of CA$20 Million..
26/4/202414:16PRNCAL'Organisme canadien de réglementation des investissements..
26/4/202414:14PRNCACanadian Investment Regulatory Organization Trade Resumption..
26/4/202414:09PRNCASuspension de la négociation par l'Organisme canadien de..
26/4/202414:07PRNCACanadian Investment Regulatory Organization Trading Halt -..
26/4/202414:00GLOBEMedicenna Therapeutics Announces CA$20 Million Investment..
24/4/202416:05GLOBEMedicenna Announces Oral Presentation of MDNA11 Data from..
10/4/202412:30GLOBEMedicenna Presents Updated Results of Single Agent MDNA11..
09/4/202422:30GLOBEMedicenna Presents Updated Results of Single Agent MDNA11..
09/4/202418:01GLOBEMedicenna Presents Updated Preclinical Data on MDNA113, a..
04/4/202413:00GLOBEMedicenna to Present at the 2024 Bloom Burton & Co...
06/3/202413:00GLOBEMedicenna to Provide Clinical Update on the MDNA11 ABILITY-1..
14/2/202413:30GLOBEMedicenna Therapeutics Reports Third Quarter Fiscal 2024..
13/2/202413:00GLOBEMedicenna Announces First Patient Dosed in ABILITY-1 Study..
12/1/202423:36GLOBEMedicenna Announces Appointment of New Auditor
09/1/202413:00GLOBEMedicenna Commences Enrollment in the ABILITY-1 Study..
22/12/202301:30GLOBEMedicenna Extends Period to Exercise Certain Warrants
19/12/202313:00GLOBEMedicenna Announces Trading on the OTCQB Under the Symbol..
14/11/202314:30GLOBEMedicenna Therapeutics Reports Second Quarter Fiscal 2024..
09/11/202314:56GLOBEMedicenna to Present 4 Year Follow-up Phase 2b Bizaxofusp..
06/11/202313:00GLOBEMedicenna Announces Promising Single-Agent Response and..
03/11/202317:00GLOBEMedicenna Presents Preclinical Data on MDNA113, its Targeted..
27/10/202313:55GLOBEMedicenna Announces Nasdaq Delisting and Cutback of..
25/10/202313:00GLOBEMedicenna Therapeutics Doses First Patient in Phase 2..
24/10/202313:15GLOBEMedicenna Announces Presentations at the 38th Annual Meeting..
10/10/202313:07GLOBEMedicenna Therapeutics Appoints Humphrey Gardner, M.D., as..
03/10/202313:00GLOBEMedicenna Presents Preclinical MDNA223 BiSKIT Data at the..
28/9/202323:00GLOBEMedicenna Announces Results of Annual and Special Meeting of..
28/9/202313:00GLOBEMedicenna to Present at the AACR Special Conference Cancer..
06/9/202313:00GLOBEMedicenna to Participate at The H.C. Wainwright 25th Annual..
28/8/202313:00GLOBEMedicenna Announces the Appointment of Jeff Caravella as..
14/8/202313:00GLOBEMedicenna Establishes Boston Presence, Appoints Brent..
08/8/202313:00GLOBEMedicenna Appoints Dr. Arash Yavari as Chair of Development..
04/8/202313:00GLOBEMedicenna Therapeutics to Provide Clinical Update from Phase..
01/8/202315:30GLOBEMedicenna Strengthens IP Portfolio with U.S. Patent Granted..
28/7/202313:00GLOBEMedicenna Reports First Quarter Fiscal 2024 Financial..
25/7/202313:00GLOBEMedicenna Presents at National Brain Tumor Society's..
05/7/202313:00GLOBEMedicenna Extends Period to Exercise Certain Warrants
27/6/202314:00GLOBEMedicenna Reports Fiscal Year 2023 Financial Results and..

Dernières Valeurs Consultées

TSX
MDNA
Medicenna Therapeutics
USOTC
DPFD
Deep Field Technologies (CE)
BIT
UC7PX4
Unicredit Bank
NYSE
ISH
International Shipholding
TG
JNJC
Johnson & Johnson
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés